Mont Royal SRL
Mont Royal reported total assets of 126,135 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Jun 2026).
The score of Mont Royal shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -18 % Total assets +7 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mont Royal's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Jun 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 25 Jul 2024
- Year ended 31 Dec 2022filed on 17 May 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Mont Royal's financial analysis
- Solvency61.2%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mont Royal
Mont Royal's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0475.669.093
- VAT number
- BE0475669093
- Peppol
- Registered · 0208:0475669093 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Sep 2001
- Registered office
- 1000 Brussels
- Latest accounts
- 2025 · filed on 18 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Mont Royal (SRL) has been based in Brussels since 2001, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 8,080 € and equity of 77,147 €; its revenue is not published. Its solvency stands at 61.2%, above the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Mont Royal
Companies in the same business, of comparable size and area, outside its group.
- Sirona Retail sale of pharmaceutical products Etterbeek · balance sheet 126,289 €
- Pharmacie VERHEYDEN Retail sale of pharmaceutical products Brussels · balance sheet 135,673 €
- Pharma Nasir Retail sale of pharmaceutical products Ixelles · balance sheet 126,608 €
- Apotheker Kaat Stas Retail sale of pharmaceutical products Mortsel · balance sheet 123,434 €
- O.Sabur Retail sale of pharmaceutical products Genk · balance sheet 129,423 €
- Medlinx Lina Retail sale of pharmaceutical products Schaerbeek · balance sheet 130,245 €
- Toelen Apotekers Retail sale of pharmaceutical products Halle · balance sheet 118,845 €
- Farma Jana Retail sale of pharmaceutical products Lo-Reninge · balance sheet 118,424 €
Frequently asked questions about Mont Royal
What is the revenue of Mont Royal?
Mont Royal files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mont Royal?
In Belgium, the VAT number is the company number prefixed with BE: BE0475669093 for Mont Royal, if the company is VAT-registered. Its company number (CBE) is 0475.669.093.
Where is the registered office of Mont Royal?
According to the CBE register, the registered office of Mont Royal is in 1000 Brussels.
What is the equity of Mont Royal?
At the close of the 2025 financial year, the equity of Mont Royal amounts to 77,147 €, a solvency of 61.2% of total assets.
Who manages Mont Royal?
The register lists 1 active mandates at Mont Royal. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mont Royal
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →